Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways. | Int J Mol Sci | 2023 | 37511468 | PubTator, text mining | PubMed |
| Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression. | Int J Mol Sci | 2023 | 37511228 | PubTator, text mining | PubMed |
| Innate Immunity in Cancer Biology and Therapy. | Int J Mol Sci | 2023 | 37510993 | PubTator, text mining | PubMed |
| Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy. | Cancers (Basel) | 2023 | 37509394 | PubTator, text mining | PubMed |
| Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension. | Pulm Circ | 2023 | 37502145 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2. | Heliyon | 2023 | 37501987 | PubTator, text mining | PubMed |
| Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models. | J Transl Med | 2023 | 37501121 | PubTator, text mining | PubMed |
| Identification of methylated differentially expressed hub genes in systemic lupus erythematosus patients by WGCNA-based epigenome-wide and transcriptome-wide analysis. | Genes Dis | 2023 | 37492718 | PubTator, text mining | PubMed |
| Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate. | Rheumatol Ther | 2023 | 37490202 | PubTator, text mining | PubMed |
| Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. | Mol Cancer | 2023 | 37488598 | PubTator, text mining | PubMed |
| CD38-Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells. | Adv Sci (Weinh) | 2023 | 37485647 | PubTator, text mining | PubMed |
| Pediatric adenovirus pneumonia: clinical practice and current treatment. | Front Med (Lausanne) | 2023 | 37476615 | PubTator, text mining | PubMed |
| Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy. | Front Mol Biosci | 2023 | 37469705 | PubTator, text mining | PubMed |
| MicroRNA-22 Regulates the Pro-inflammatory Responses and M1 Polarization of Macrophages by Targeting GLUT1 and 4-1BBL. | J Immunol Res | 2023 | 37469388 | PubTator, text mining | PubMed |
| TNF superfamily control of tissue remodeling and fibrosis. | Front Immunol | 2023 | 37465675 | PubTator, text mining | PubMed |
| Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma. | Front Immunol | 2023 | 37465666 | PubTator, text mining | PubMed |
| T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions. | Front Oncol | 2023 | 37465110 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37462769 | PubTator, text mining | PubMed |
| Cord blood-derived CD19-specific chimeric antigen receptor T cells: an off-the-shelf promising therapeutic option for treatment of diffuse large B-cell lymphoma. | Front Immunol | 2023 | 37449207 | PubTator, text mining | PubMed |
| Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions. | Cancers (Basel) | 2023 | 37444436 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=20